BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li F, Wang Z, Hu F, Su L. Cell Culture Models and Animal Models for HBV Study. Adv Exp Med Biol 2020;1179:109-35. [PMID: 31741335 DOI: 10.1007/978-981-13-9151-4_5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lai F, Wee CYY, Chen Q. Establishment of Humanized Mice for the Study of HBV. Front Immunol 2021;12:638447. [PMID: 33679796 DOI: 10.3389/fimmu.2021.638447] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ouchida T, Takamatsu S, Maeda M, Asuka T, Morita C, Kondo J, Ueda K, Miyoshi E. Challenges in the Application of Glyco-Technology to Hepatitis B Virus Therapy and Diagnosis. Viruses 2021;13:1860. [PMID: 34578441 DOI: 10.3390/v13091860] [Reference Citation Analysis]
3 Guo Y, Cai X, Lu H, Li Q, Zheng Y, Lin Z, Cheng Z, Yang M, Zhang L, Xiang L, Yang X. 17β-Estradiol Promotes Apoptosis of HepG2 Cells Caused by Oxidative Stress by Increasing Foxo3a Phosphorylation. Front Pharmacol 2021;12:607379. [PMID: 33790784 DOI: 10.3389/fphar.2021.607379] [Reference Citation Analysis]
4 Capozza P, Decaro N, Beikpour F, Buonavoglia C, Martella V. Emerging Hepatotropic Viruses in Cats: A Brief Review. Viruses 2021;13:1162. [PMID: 34204394 DOI: 10.3390/v13061162] [Reference Citation Analysis]
5 Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, Lu M. In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application. Front Immunol 2021;12:766534. [PMID: 34777385 DOI: 10.3389/fimmu.2021.766534] [Reference Citation Analysis]
6 Arez F, Rodrigues AF, Brito C, Alves PM. Bioengineered Liver Cell Models of Hepatotropic Infections. Viruses 2021;13:773. [PMID: 33925701 DOI: 10.3390/v13050773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Buhlig TS, Bowersox AF, Braun DL, Owsley DN, James KD, Aranda AJ, Kendrick CD, Skalka NA, Clark DN. Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target. Viruses 2020;12:E570. [PMID: 32455999 DOI: 10.3390/v12050570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Lin X, Tang J, Lou YR. Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development. Pharmaceuticals (Basel) 2021;14:525. [PMID: 34070895 DOI: 10.3390/ph14060525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Luan F, Liu B, Guo X, Yong W. Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.111618] [Reference Citation Analysis]
10 Liu Z, Wang J, Yuan H, Liu L, Bu Y, Zhao M, Yang G, Feng J, Liu Y, Li J, He Q, Zhang X. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver. Biochem Biophys Res Commun 2020;527:76-82. [PMID: 32446394 DOI: 10.1016/j.bbrc.2020.04.057] [Reference Citation Analysis]